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Fast-scan cyclic voltammetry (FSCV) is a powerful tool forstudying in vivo, subsecond neurotransmitter dynamics.14
Miniaturization of the electronics associated with FSCV has
allowed correlation of transient dopamine concentration fluctua-
tions with behavior in freely moving rats.5,6 These behavioral
experiments necessitate a “survival” surgery in which an electrical
stimulating electrode, a guide cannula, and a Ag/AgCl reference
electrode are permanently implanted into the brain of a rat. After
a recovery period (typically 4 days), the rat is placed in an operant
chamber and a fresh carbon-fiber electrode is lowered into the
brain for voltammetric recordings of dopamine during beha-
vior. These recordings often yield cyclic voltammograms where
the oxidation and reduction potentials associated with dopa-
mine redox processes are “shifted” with respect to in vitro
recordings. This electrochemical shift, typically of +0.20.3 V,
can have dramatic effects on the voltammetric measurements.
First, the identification of the species electrolyzed, which is
based upon the position of the voltammetric peaks, is con-
founded. Second, the sensitivity of the responses is altered
because the voltammetric response to adsorbed species de-
pends upon the potential limit of the voltage scan.7 These
electrochemical shifts arise from a drift in response of the
chronically implanted reference electrode because they are not
seen with acute implantation.8,9
Deterioration of probes permanently implanted in the brain is
commonly seen in a variety of experiments,1012 and the brain’s
response toward implanted devices has been well-documented.1316
When a foreign body is inserted into the tissue, a dense network
of glial cells encapsulates the device, isolating it from the tissue in
a process called gliosis or glial scarring.1719 For FSCV measure-
ments, the electrochemical shift affects the quantification of
dopamine levels and reproducibility of substrate identity. In
the past, we have offset the potential shift. While this approach
is effective, it is desirable to prevent the shift from occurring so
that the potentials employed in the brain are accurate.
In this paper, we demonstrate a method that minimizes this
electrochemical shift. Past research has focused on strategically
shaping, texturing, coating, or optimizing materials for devices to
reduce tissue responses.10,2023 In 1994, Moussy and Harrison
found that the rapid subcutaneous degradation of Ag/AgCl could
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ABSTRACT: Fast-scan cyclic voltammetry at carbon-fiber
microelectrodes can be used to measure behaviorally correlated
dopamine changes in the extracellular fluid of the brain of freely
moving rats. These experiments employ a chronically implanted
Ag/AgCl reference electrode. When dopamine measurements
are taken 4 days after implantation, there is often a potential
shift, typically greater than +0.2 V, in the anodic and cathodic
peaks in the cyclic voltammogram for dopamine. In this work,
we optimized a method to coat sintered Ag/AgCl reference
electrodes with the perfluorinated polymer, Nafion, to prevent
this shift. We find that we can stabilize reference electrodes for up to 28 days. Immunohistochemistry of the tissue around the
implant site shows extensive glial encapsulation around both bare and Nafion-coated devices. However, the lesion around bare
electrodes has a rough texture implying that these cells are strongly adsorbed onto the bare reference electrode, while the lesion
around a Nafion-coated electrode shows that cells are more intact implying that they adsorb less strongly. Energy dispersive X-ray
spectroscopy and scanning electron microscopy analysis of the surface of the electrodes confirms this by visualizing a heavy buildup
of plaques, organic in nature, only on bare electrodes. Impedance spectroscopy indicates no difference between the impedance of
bare and Nafion-coated Ag/AgCl electrodes, indicating that glial encapsulation does not lead to an increase in uncompensated
resistance between the working and reference electrodes. The electrochemical shift therefore must be due to the unique chemical
microenvironment around the reference electrode that alters the chloride equilibrium, a process that the Nafion coating prevents.
KEYWORDS: Astrocytes, glia, fast-scan cyclic voltammetry, carbon-fiber microelectrode, dopamine, in vivo, neuroinflammation,
peak shift, surface analysis, impedance spectroscopy
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be prevented with Nafion modifications to the reference elec-
trode surface.24 Here, we optimize their method and apply it to
in vivo neurochemical FSCV. We found that we could stabilize
our reference electrodes with this method for up to 28 days. Via
immunohistochemistry of the tissue at the implant site and
surface analysis of the electrodes, we found that the mechanism
of this increased stability was consistent with the extent of glial
cells physically adhered onto the electrode’s surface, a process
that Nafion prevents. Using electrical impedance measurements,
we found that this effect is not electrical but rather most likely due
to chemical changes in the microenvironment of the glial cells.
’RESULTS AND DISCUSSION
Electrochemical Shift in Peaks for Dopamine Oxidation
and Reduction 4 Days after Implantation. FSCV experiments
in behaving rats require a period of recovery after the surgery to
implant the reference and stimulating electrodes. Within this 4
day period, chemical or physical processes occur around the
reference electrode surface such that when dopamine is mea-
sured with a fresh carbon-fiber microelectrode, the oxidation and
reduction potentials are “shifted” with respect to their in vitro
positions. Figure 1A illustrates this type of response in a freely
moving rat that had undergone surgery 4 days previously. The
color plot in panel (i) displays cyclic voltammograms collected at
10 Hz for 15 s in the NAc during an electrical stimulation (at 5 s)
of the MFB. The time of the electrical stimulation is indicated
with the black bar under the color plot. This electrically evoked
response has previously been characterized anatomically, phy-
siologically, chemically, and pharmacologically to arise from
neuronal release of dopamine.1 However, the peaks for this
substance recorded in vivo do not occur at the same potential as
those for authentic dopamine (1 μM) measured in vitro
(Figure 1C) using a freshly fabricated Ag/AgCl electrode. This
is also apparent in the corresponding cyclic voltammograms
shown in panel (ii) of Figure 1. In vivo, the oxidation occurs at
around 0.95 V instead of 0.65 V and the reduction occurs at 0.0 V
instead of 0.2 V, showing that a process at the implanted
reference electrode has offset the potential of the applied wave-
form. Moreover, this change in waveform seems to enhance
sensitivity to the pH changes that occur after the stimulation,
making it more difficult to distinguish smaller dopamine signals.
We have previously compensated for this by applying a counter
potential offset as illustrated in Figure 1B where the horizontal
white dashed lines show the position of the maximum oxidation
with respect to the in vitro signal. In this example, the waveform
was offset by 300 mV, which shifts the oxidation response to
0.65 V and the reduction to0.2 V. This response then matches
the in vitro response (Figure 1C).
Interestingly, the potential of this “shifted” reference electrode
is not permanently altered. To establish this, we removed the
reference electrode from the rat’s brain and used it as a reference
electrode in vitro for dopamine measurements. Figure 1D shows
that, despite the shifted electrochemical response in vivo, the
reference electrode yields an electrochemically characteristic dopa-
mine cyclic voltammogram that is not offset in vitro. Thus, the
mechanisms leading to the electrochemical shifts are specific to
the local environment around the reference electrode in vivo.
Prevention of Electrochemical Shift with Nafion-Coated
Ag/AgCl Reference Electrodes. In our previous work, and in
the example shown in Figure 1, we constructed Ag/AgCl reference
electrodes by electroplating AgCl onto a silver wire.25 Because
this resulted in a thin chloride layer, it may be particularly sus-
ceptible to an alteration in chemical composition when im-
planted in the brain. Thus, we used commercially available,
sintered Ag/AgCl electrodes (E255A, In Vivo Metric, Healds-
burg, CA). The Ag/AgCl is sintered in a mesh matrix, and a Ag
wire is forced into the matrix to create the electrode that has a
much thicker AgCl coating than the homemade reference electrodes.
However, despite the thicker chloride layer, these electrodes also
showed a potential shift of similar magnitude in vivo 4 days after
implantation.
Figure 1. (i) Color plots with potential on the y-axis plotted against time on the x-axis and the current response represented in false color. These plots
represent (A) the signal obtained in the NAc of a freely moving rat upon MFB stimulation (black bar under the color plot denotes the stimulation time
and duration) 4 days after initial surgery, (B) the same signal after a0.3 V “offset”, (C) an in vitro injection of dopamine (1 μM) vs a fresh Ag/AgCl
reference electrode, and (D) an in vitro injection of dopamine (1 μM) vs the Ag/AgCl electrode explanted from the rat used in signal (A). (ii) (AD)
Representative cyclic voltammograms taken from the vertical white dashed lines.
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Moussy and Harrison previously described Nafion coatings on
Ag/AgCl reference electrodes that prevented the degradation of
their electrochemical performance.24We have previously utilized
Nafion extensively in our electrochemical recordings;3,26,27 therefore,
we optimized their coating technique in an attempt to stabilize
the potential of our reference electrodes. The sintered electrodes
were used because their rough surface is ideal for adherence of
polymer coatings. The electrodes were dipped five times in 5%
Nafion solution for 10 s with a slow agitating motion, and each
coating was allowed to dry for 30 min. These electrodes were
dried in air overnight and then cured at 120 C for 1 h. To test
their stability, we performed experiments where we implanted
both Nafion and uncoated reference electrodes into the brains of
rats whowere then allowed to recover for 7, 14, and 28 days. After
these periods, the rats were anesthetized, an acute reference
electrode and carbon fiber electrode were implanted into their
brain, and dopamine release was compared with recordings using
each of the three reference electrodes (acute, Nafion-coated,
permanently implanted and bare, permanently implanted).
Figure 2A (i) shows a color plot of the dopamine response in
the NAc of an anesthetized animal upon MFB stimulation when
the potential was applied versus the acutely implanted Ag/AgCl
reference electrode. Figure 2B (i) and C (i) shows comparisons
of this same response, at the same carbon-fiber microelectrode in
the same rat, however, versus bare (B) and a Nafion-coated (C)
chronically implanted reference electrodes that had been im-
planted for 7 days. Panel (ii) shows the corresponding cyclic
voltammograms. As before, the bare electrode displays shifted
oxidation and reduction peaks (0.93 and 0.08 V, respectively);
however, the Nafion-coated reference electrode prevents this
effect. The positions of the oxidation and reduction peaks are
maintained and correlate not only with the acutely implanted
reference electrode, as indicated by the horizontal white dashed
line, but also to an in vitro experiment (0.65 and 0.2 V, respec-
tively). This effect is maintained over multiple days. Figure 2 (iii)
shows a histogram that compares dopamine potential shifts
between acutely implanted reference electrodes and bare (blue)
and Nafion-coated (black) electrodes that have been implanted
into the brain for 7, 14, and 28 days (n = 6 for each group (18 in
total) ( SEM). The bare electrodes display shifts in all cases,
Figure 2. (i) Color plots with potential on the y-axis plotted against time on the x-axis and the current response represented in false color. These plots
represent (A) a dopamine signal in the NAc of an anesthetized rat upon MFB stimulation (stimulation time and duration noted by black bar under the
plot) vs an acutely implanted Ag/AgCl reference electrode, (B) a dopamine signal in the same rat vs a bare electrode implanted for 7 days, (C) a
dopamine signal in the same vs a Nafion-coated electrode implanted for 7 days. (ii) (AC)Representative cyclic voltammograms taken from the vertical
white dashed lines. (iii) Averaged volts shifted from an acutely implanted Ag/AgCl reference electrode for bare (blue) and Nafion-coated (black)
electrodes for 7, 14, and 28 days (n = 6 per group (18 in total)( SEM). Results were analyzed using a two-way ANOVA showing a significant difference
in potential shift between bare and Nafion electrodes (P < 0.001) and post-tests to compare groups at the different time points; *P < 0.05, **P < 0.01.
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most robustly after 28 days as evidenced by the small error
margin. The Nafion coated electrode reduces this shift, however.
We analyzed the shifts in peak potential using a two-way
ANOVA, with appropriate post-tests, and found that Nafion
coatings had a significantly different behavior than the bare
electrodes on potential over time (P < 0.001). Using the post-
tests, it was determined that there was no significant difference
between the groups after 1 week implantation (P > 0.05), but a
significant difference after 2 and 4 weeks of implantation (P <
0.01 and P < 0.05, respectively). We can therefore increase the
stability of the reference electrodes robustly and significantly for
up to 28 days using this technique.
Immunohistochemical Analysis of Implant Site in Tissue.
To better understand how Nafion coating prevents the electro-
chemical shift, we performed immunohistochemical analysis of
the cortical tissue around the reference electrode implantation
site. Figure 3 (i) shows fluorescence images of antibody binding
to glial fibrillary acid protein (GFAP) around the lesion site
where the reference electrodes were explanted after 14 days for
(A) bare and (B) Nafion-coated electrodes. GFAP is expressed
only in glial cells; therefore, a higher degree of fluorescence
corresponds to a larger density of glial cells. Figure 3 (ii) shows
extensive immunoreactivity to GFAP antibody. Glial scarring is
present in the lesion surrounding the implantation site of both
Nafion-coated and bare reference electrodes. However, the
lesion sites of Nafion-coated electrodes (B) have a qualitatively
different appearance around the implant border after the elec-
trode is removed. The implant border of the lesion around the
bare electrodes is rough in appearance and implies that the cells
are disrupted or torn after electrode removal. The implant border
of the lesion around the Nafion-coated electrodes has a smooth
appearance, implying that cells are less disturbed by electrode
removal. This difference is also apparent in the bright field images
in Figure 3 (ii) that compare bare (top) versus Nafion-coated
(bottom) electrodes after 7 days (C), 14 days (D), and 28 days
(E) post-implantation. In all cases, the implant borders of the
lesions left after removal of the Nafion-coated electrodes have a
smoother appearance, showing more cells intact. The difference
in roughness around the lesion sites may be due to the Nafion’s
hydrophobic properties that prevent glial cells from adhering to
the electrode surface. The extent of glial scarring is dependent on
the dimensions of the device,28 and since the bare and Nafion-
coated electrodes are equivalent in size, the immune response to
them should be comparable. However, because the cells adhere
strongly to the bare-electrode surface, once this electrode is
removed, they may effectively be “ripped” out during electrode
removal. The glial cells however adsorb less strongly to the Nafion
surface; hence, when this electrode is removed, more cells remain
intact in the tissue. This appears to be the case up until 28 days where
the implant border of the lesion left after removal of the Nafion-
coated electrode (E) also appears rough. This agrees with the
voltammetric data that showed electrochemical shifts beginning to
occur at 28 days. Therefore, the extent of intact glial cells around the
lesion site of the electrode is consistent with the electrochemical shift.
SEM/EDS Analysis of Electrode Surface. We next analyzed
the surface of the reference electrodes after their removal from
Figure 3. Glial fibrallary acid protein (GFAP) immunoreactivity in cortical astroglia after reference electrode removal. (i) Fluorescence images of the
tissue around the implant site of (A) a bare Ag/AgCl reference electrode and (B) a Nafion-coated electrode after 14 days. (ii) Bright images of GFAP
immunoreactivity around representative lesion sites for bare (top) and Nafion-coated (bottom) electrodes for 7 days (C), 14 days (D), and 28 days (E).
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the brain with scanning electron microscopy (SEM) and energy
dispersive X-ray spectroscopy (EDS). Figure 4 contains SEM
images of bare (i) and Nafion-coated (ii) electrodes before
implantation (A) and after 28 days (B) in the rat brain. Before
implantation, there is a clear visual difference between the bare
electrode and the Nafion-coated electrodes. The bare electrodes
have a coarse appearance due to the sintered Ag/AgCl surface,
while the Nafion-coated electrodes appear smoother. The shiny
appearance of the Nafion is easily distinguishable from the
Ag/AgCl. As implantation time is increased, a buildup of large
plaques is apparent on the bare electrode surface; this is particu-
larly striking after 28 days (B) and is highlighted with the focused
image in (C). In contrast, the Nafion-coated surfaces (ii) remain
free of plaques. This is consistent with the histological data
that shows that the cells remain intact in the tissue and indeed
with the voltammetric data that shows no electrochemical shifts.
However, as implantation time is increased up to 28 days (B), the
Nafion-coated electrode resembles a bare electrode, showing
that the Nafion coating has degraded. The 28-day marker is
again consistent with the voltammetric data that shows a small
percentage of electrodes that shift after 28 days and with the
histological data that shows a rough surface lesion around the
Nafion-coated electrode’s implant site in tissue.
We next chemically analyzed three distinct sites on the
electrode’s surface with EDS. EDS displays high spatial resolu-
tion with an ability to measure the elemental content of the
material at depth of several micrometers. Hence, we can observe
the Ag present under the Nafion coatings. Figure 5 shows
representative EDS spectra for (A) a bare electrode pre-implan-
tation, (B) a Nafion-coated electrode pre-implantation, (C) a
bare electrode after 14 days post-implantation, and (D) aNafion-
coated electrode 14 days post-implantation. Peaks were quanti-
fied as the atomic percent of each species observed. The Nafion-
coated electrodes display the same peak positions as the bare
electrodes (Ag doublet at 3 keV; Cl peaks at 0.1 and 2.8 keV) and
in addition have peaks for carbon (peak at 0.3 keV), sulfur (peak
at 2.3 keV), and fluorine (peak at 0.7 keV), key components of
the nonpolar perfluorinated coating. After 14 days, additional
peaks can be observed on the bare electrodes including carbon
and oxygen (peak at 0.6 keV). This confirms that the composi-
tion of the hard plaques apparent in Figure 4 are organic,
providing yet more evidence that cells are adsorbing to the bare
electrode surface. We can quantify the Nafion levels on the
electrode surface bymeasuring the atomic percent of fluorine as a
function of implantation time. Figure 5E shows that the content
of fluorine on the surface of the electrode is around 60% before
implantation. After 7 days, the content is around 50% (P < 0.05
compared to pre-implantation). At 14 days, the fluorine content
is around 30% (P < 0.001 compared to pre-implantation) and
dramatically lower after 28 days at around 7% (P < 0.001
Figure 4. Representative scanning electron microscopy images of bare
(i) and Nafion-coated (ii) electrodes before implantation in the brain
(A) and after 28 days implantation (B) in the brain, and (C) zoomed
section as outlined by the white box.
Figure 5. Representative EDS spectra for Ag/AgCl reference electrodes uncoated before brain implantation (A), Nafion-coated before brain
implantation (B), uncoated after 2 weeks brain implantation (C), and Nafion-coated after 2 weeks brain implantation (D). Peaks are labeled indicating
the atom they represent. (E) Atomic percent fluorine on the surface of Nafion-coated electrodes after 0, 7, 14, and 28 days brain implantation (*P < 0.05,
***P < 0.001, one-way ANOVA with appropriate post hoc test compared to 0 days). (F) Normalized, atomic percent chlorine on the surface of Nafion-
coated (white) and bare (black) electrodes after 0, 7, 14, and 28 days brain implantation (Student’s t test was performed on unpaired data; *P < 0.05 was
taken as significant).
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compared to pre-implantation). These data quantitatively sup-
port the visual observation from Figure 4 that the Nafion coating
can fail after 28 days. Furthermore, when we do the same analysis
for chlorine on bare versus Nafion-coated electrodes (Figure 5F),
we find a decrease in the chlorine levels in both cases. When
normalized, the chlorine levels are relatively more abundant after
14 and 28 days post-implantation on the Nafion coated electro-
des as compared to the bare electrodes. This implies that the
electrochemical shift is dependent on a critical level of chloride
on the surface. Because Nafion is a cation-exchange polymer, it is
likely that it protects the chloride ion equilibrium at the reference
electrode surface. Accordingly, EDS analysis of the Nafion-coated
surface shows that although the absolute levels of chlorine are smaller
on the Nafion-coated surface (due to the Nafion coating), the levels
drop less significantly at 14 and 28 days (p < 0.05).
The data from these studies support the notion that theNafion
coatings on reference electrodes are stable up to 28 days in the rat
brain. Cell adsorption onto the reference electrodes is consistent
with the loss of chlorine on the surface and subsequently with the
electrochemical shift. Viable Nafion coatings prevent cell adsorp-
tion, maintaining the chlorine layer, hence preventing electro-
chemical shifts.
Origin of Electrochemical Peak Shift. A peak shift in cyclic
voltammograms can have several origins. The recordings shown
here were done with freshly implanted carbon fiber electrodes
employing a uniform scan rate29 and constant filtering, so these
factors and changes in electron transfer kinetics are not respon-
sible for these observations. Changes in the media resistance or a
change in the standard electrode reference potential are two
other possible causes. The formation of the glial scar and inevitable
encapsulation of the foreign body by astrocytes at chronically
implanted electrodes1719 both could increase the impedance.30
Therefore, we measured the impedance of bare (black) and
Nafion-coated electrodes (blue) for acutely implanted electrodes
in Figure 6A and after 14 days implantation in Figure 6B. We
found negligible differences in the impedance between these
two electrodes at all frequencies. A two-way ANOVA with post-
tests showed no significant difference between the impedance
of bare and Nafion coated electrodes over 7, 14, and 28 days
(n = 3 ( SEM each group, P > 0.05 for all data). Furthermore,
Figure 6C shows the impedance value at 200 kHz where the
impedance is dominated by the resistance of the media. Collec-
tively, these data show that the increased gliosis around the
reference electrode does not lead to increased resistance between
the working and reference electrodes.
Thus, the most likely origin of the potential shift with
chronically implanted bare reference electrodes is a chemical
change in or around its surface. Our EDS data (Figure 5F) reveal
Figure 6. (A) Impedance of reference electrodes: Frequency dependent impedance of the reference electrodes measured versus acutely implanted Ag/
AgCl electrodes right after implantation (0 days) and after 28 days of chronic implantation (B) for bare and Nafion-coated electrodes. (C) Time course
of changes in impedance at 200 kHz for bare (B) andNafion-coated (N) electrodes immediately after implantation (0, B and 0, N), after 7 days (7, B and
7, N), after 14 days (14, B and 14, N), and after 28 days (28, B and 28, N), respectively (n = 3 rats for each data point). Data were analyzed with a two-way
ANOVA with post-tests to compare groups; P > 0.05 for all comparisons showing no significant differences in impedance between groups over various
implantation times.
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a decrease in available surface chlorine of the bare electrodes in
the brain, consistent with this hypothesis. However, reference
electrodes that yield shifted cyclic voltammograms in vivo do not
demonstrate the shift once explanted and used in vitro
(Figure 2). This may be because the adsorbed cells wash off
the explanted electrode in vitro, exposing more of the Ag/AgCl.
Alternatively, the artificial cerebrospinal fluid used as the buffer in
vitro may replenish the choride layer. These factors would
reinstate the chloride equilibrium of the Ag/AgCl.
These data reveal that there is a change in the functional
chemical microenvironment around the reference electrodes
in vivo. Based on the literature documenting the roles of glial
cells in immune-defense, there are two possible mechanisms.
First, the formation of a glial scar is thought to create an ion-
impermeable barrier, much like the blood-brain barrier around
the implanted device.31 This barrier is largely impermeable to
ions and may effectively shift the ionic equilibrium near the
reference electrode surface. Nafion, a cation exchange polymer,
could create an anionic (Cl) buffer zone between the glial scar
and the electrode surface. Alternatively, glial cells do not passively
encapsulate the device, but rather they actively secrete cytotoxic
chemicals onto the device in order to inactivate it. These
include nitric oxide,32 reactive oxygen intermediates (ROIs),
hydrogen peroxide, and superoxide.33 These chemicals could
disrupt the Cl equilibrium of the reference electrode; Nafion’s
cation exchange properties would repel some of these species,
in particular superoxide, maintaining the reference properties of
a Nafion-coated reference electrode. This cannot be mimicked
easily in vitro due to superoxide’s short lifetime in solution.
In conclusion, we have shown that we can prevent electro-
chemical shifts in fast cyclic voltammetric recordings that occur
due to chronic implantation of reference electrodes with Nafion
coatings on the Ag/AgCl surface. We linked the stability of our
electrodes with the levels of Nafion on the electrode surface and
showed that the Nafion stops cell adsorption onto the reference
electrodes and maintains the integrity of the Ag/AgCl surface.
We show several lines of evidence that strongly suggest that the
shift is due to a change in the chemical microenvironment around
the reference electrode because of the physical or chemical
processes incurred by the glial scar.
’METHODS
Animals and Surgery. Surgery for voltammetric measurements of
dopamine were performed as previously described.25 Briefly, male
SpragueDawley rats aged 90120 days (275350 g) (Charles River
Laboratories., Raleigh, NC) were anesthetized with urethane (1.5 g kg 1
rat weight) and affixed into a stereotaxic frame (Kofp instruments). Flat-
skull surgical techniques were employed using coordinates from a
stereotaxic atlas.34 A guide cannula (Bioanalytical Systems, West Lafay-
ette, IL) was implanted above the nucleus accumbens (NAc)
(stereotaxic coordinates relative to bregma: 2.2 mm anterior, 1.7 mm
lateral), and a bipolar stimulating electrode (Plastics One, Roanoke, VA)
was lowered into the medial forebrain bundle (MFB) (stereotaxic
coordinates relative to bregma: 1.8 mm posterior, 1.7 mm lateral, 8.5
mm ventral). Reference electrodes (prepared as described below) were
implanted in the contralateral hemisphere. Electrodes were stabilized
with skull screws and cranioplastic cement. After voltammetry and
impedance experiments, acetone was applied to the cement around the
reference electrode in order to soften it. A small crater was drilled around
the reference electrode pin so that it could be removed carefully from
the tissue, minimizing tissue damage. All surgical procedures were
approved by the University of North Carolina Institutional Animal Care
and Use Committee and in concordance with the NIH Guide for the
Care and Use of Animals.
Fast-Scan Cyclic Voltammetry. Carbon-fiber microelectrodes
were used for voltammetric recordings of dopamine. T-650 carbon fibers
(Thornel, Amoco Corp., Greenville, SC) were aspirated into glass
capillaries (AM Systems, Sequim, WA), pulled on a vertical pipet puller
(model PE-22, Narishige Group, Tokyo, Japan), and cut to a length of
50100 μm. An electrochemical waveform was applied to the electrode
that scanned from 0.4 to 1.3 V at a rate of 400 V s1 at 10 Hz. The
holding potential of 0.4 V between voltammetric scans allows for
adsorption of dopamine to the electrode. Waveform application, current
monitoring, and stimulus application were performed using a custo-
mized version of the TH-1 software (ESA, Chelmsford, MA) written
in LabVIEW (National Instruments, Austin, TX) with a custom built
potentiostat (UEI, University of North Carolina Chemistry Department
Electronics Facility) for waveform application. A DAC/ADC card
(NI 6251 M, National Instruments) and a triggering card (NI 6711,
National Instruments) were used to interface between the software
and the instrument and the timing of the electrical stimulation with
the waveform application.
Flow Injection Analysis. Flow injection analysis was used for in
vitro calibration experiments.35 The carbon-fiber microelectrode was
placed in the output of a six-port HPLC loop injector mounted on a two-
position actuator (Rheodyne model 7010 valve and 5701 actuator),
operated by a 12 V DC solenoid valve kit (Rheodyne, Rohnert Park,
CA). The apparatus enabled the introduction of a rectangular pulse of
analyte to the microelectrode surface using a syringe infusion pump
(Harvard Apparatus model 940, Hollison, MA) at a flow rate of 2 mL/
min. The flow injection buffer was constituted with the following:
Trizma hydrochloride (15 mM), NaCl (140 mM), KCl (3.25 mM),
2H2O 3CaCl (1.2 mM), H2O 3 NaH2PO4 (1.25 mM),MgCl2 (1.2 mM),
and Na2SO4 (2.0 mM), all purchased from Sigma-Aldrich (St. Louis, MO).
Nafion Coatings. Reference electrodes were fabricated using a
modified procedure originally described by Moussy and Harrison.24
Sintered Ag/AgCl reference electrodes (E255A, In Vivo Metric, Healds-
burg, CA) were mounted and soldered into conductive pins. The
entirety of the electrode was dipped in 5% Nafion solution (Liquion-
1105-MeOH, Ion Power, DE) for 10 s using a slow agitating motion.
This coating was allowed to dry for 30min, and the process was repeated
for a total of five coatings. The electrodes were air-dried overnight and
then cured at 120 C for 1 h. Because of the toxic nature of the methanol
solvent, the curing process at 120 C is essential to ensure full evap-
oration of the methanol from the thick Nafion membrane.
Immunohistochemistry. After completion of voltammetric and
impedance experiments, rats were transcardially perfused with ice-cold
0.1 M PBS, pH 7.4, followed by ice-cold 4% paraformaldehyde in 0.1 M
PBS, pH 7.4. Brains were stored in 4% paraformaldehyde for 7 days and
then sliced into 40 μM sections using a vibratome (VT1000S, Leica,
Bannockburn, IL). Slices were washed three times for 10 min each in
0.1 M PBS and then incubated in Citra Antigen Retrieval Buffer
(Biogenex, Freemont, CA) for 1 h at 70 C. Slices were again washed
in 0.1 M PBS and then incubated in 3% hydrogen peroxide for 10 min.
Slices were then washed three additional times for 10 min each before
being incubated in 10% goat serum with 0.075% Triton X-100 for 1 h at
room temperature. Primary antibody (glial fibrillary acidic protein, GFAP;
DAKO Chemical, Carpentieria, CA) was then applied to the slices at
1:1000 at 4 Covernight. Primary antibody was removed from the slices by
three washes of 0.1 M PBS. For light microscopy, secondary antibody
(biotinylated goat anti-rabbit; Vector Laboratories, Burlingame, CA) was
then applied at 1:200 at room temperature for 1 h. Slices were washed three
times in PBS, and avidinbiotin-horseradish peroxidase complex (ABC
Elite kit; Vector Laboratories) was applied for 1 h at room temperature.
Slices were then washed three more times in PBS and exposed to a
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solution of 3,30-diaminobenzidine (DAB; 0.5 mg/mL in PBS; Sigma-
Aldrich, St. Louis, MO) for 1 min. DAB was removed by three additional
washes with PBS. Slices were mounted on Superfrost Plus slides (Fisher
Scientific, Pittsburgh, PA), dried overnight, subjected to dehydration
in graded ethanol followed by clearing in CitriSolv (Fisher Scientific),
and finally coverslipped using Cytoseal (Richard Allen Scientific,
Kalamazoo,MI).Micrographswere collected using anOlympusmicroscope
attached to a Q-Imaging camera and controlled using BioQuant imaging
software (Nashville, TN).
For fluorescence microscopy, hydrogen peroxide exposure was omitted
and secondary antibody (AlexaFluor 600; Invitrogen, Carlsbad, CA) was
applied at 1:200 at room temperature for 1 h in the dark. Secondary
antibody was removed by three washes of PBS, and slices were wet-
mounted on Superfrost Plus slides using Cytoseal. Fluorescence micro-
graphs were obtained using the same setup as above.
SEM-EDS. Scanning electron microscopy and energy dispersive
X-ray spectroscopy (SEM-EDS) were performed on an S-4700 cold
cathode field emission scanning electron microscope (Hitachi, Pleasan-
ton, CA). SEM images were collected under high vacuum, using an
excitation voltage of 20 kV. EDS data were collected using a Si (Li)
detector and quantified using the INCA PentaFET -x3 software (Oxford
Instruments, Concord, MA), and calibrated using 99% Cu. EDS spectra
were collected at three distinct 300  300 μm2 locations on each
electrode, and the values for atom% fluorine and chlorine were averaged.
Impedance Measurements. Impedance measurements were
performed in anesthetized animals immediately after voltammetric mea-
surements using a Hewlett-Packard 4284A precision LCR meter with
Agilent 16048A test leads (Santa Clara, CA). The instrument was PC
operated via a USB-GPIB interface with in-house LabView based
(National Instruments, Austin, TX) software (UNC Chemistry Electro-
nics Facility). Impedance for Nafion-coated and bare Ag/AgCl reference
electrodes was measured versus an acutely implanted 1 cm long Ag/
AgCl electrode. Impedance spectra for perturbation of 50 mV for
frequencies from 20 Hz to 200 kHz were recorded.
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